Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the world. Through its proprietary TAAP technology Ensysce is in the process of receiving approval for an abuse-resistant yet still pain-relieving opioid. The company announced that data from its study of its overdose protection drug showed the compound to be effective and safe-furthering the case for FDA approval of this much-needed treatment.